Insmed Inc (INSM)
73.15
-0.66
(-0.89%)
USD |
NASDAQ |
Nov 22, 16:00
73.10
-0.05
(-0.07%)
After-Hours: 20:00
Insmed Profit Margin (Quarterly): -236.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -236.0% |
| June 30, 2024 | -332.8% |
| March 31, 2024 | -208.1% |
| December 31, 2023 | -222.3% |
| September 30, 2023 | -201.0% |
| June 30, 2023 | -317.0% |
| March 31, 2023 | -245.0% |
| December 31, 2022 | -270.0% |
| September 30, 2022 | -193.6% |
| June 30, 2022 | -146.6% |
| March 31, 2022 | -178.2% |
| December 31, 2021 | -201.3% |
| September 30, 2021 | -241.1% |
| June 30, 2021 | -258.6% |
| March 31, 2021 | -227.9% |
| December 31, 2020 | -246.8% |
| September 30, 2020 | -145.9% |
| June 30, 2020 | -145.6% |
| March 31, 2020 | -180.0% |
| December 31, 2019 | -115.9% |
| September 30, 2019 | -156.1% |
| June 30, 2019 | -221.9% |
| March 31, 2019 | -338.6% |
| December 31, 2018 | -931.1% |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | -76.99% |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-332.8%
Minimum
Jun 2024
-115.9%
Maximum
Dec 2019
-215.7%
Average
-215.2%
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -22.27% |
| Amicus Therapeutics Inc | -4.75% |
| Collegium Pharmaceutical Inc | 5.86% |
| enVVeno Medical Corp | -- |
| Fulcrum Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -56.29% |
| Return on Invested Capital | -85.94% |
| Gross Profit Margin (Quarterly) | 77.34% |
| Operating Margin (Quarterly) | -212.7% |
| Return on Net Operating Assets | -200.4% |